These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

623 related items for PubMed ID: 17649770

  • 1. Clinical value of bisphosphonates in cancer therapy.
    Lüftner D, Henschke P, Possinger K.
    Anticancer Res; 2007; 27(4A):1759-68. PubMed ID: 17649770
    [Abstract] [Full Text] [Related]

  • 2. Bisphosphonates for cancer patients: why, how, and when?
    Body JJ, Mancini I.
    Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
    [Abstract] [Full Text] [Related]

  • 3. Antitumor effects of bisphosphonates: promising preclinical evidence.
    Guise TA.
    Cancer Treat Rev; 2008 Jul; 34 Suppl 1():S19-24. PubMed ID: 18486348
    [Abstract] [Full Text] [Related]

  • 4. Emerging strategies in bone health management for the adjuvant patient.
    Coleman RE.
    Semin Oncol; 2007 Dec; 34(6 Suppl 4):S11-6. PubMed ID: 18068485
    [Abstract] [Full Text] [Related]

  • 5. New results from the use of bisphosphonates in cancer patients.
    Coleman R, Gnant M.
    Curr Opin Support Palliat Care; 2009 Sep; 3(3):213-8. PubMed ID: 19561507
    [Abstract] [Full Text] [Related]

  • 6. [Current use of bisphosphonates in clinical oncology].
    Vrbanec D, Plestina S, Belev B, Unusić J, Pavlinić-Diminić V.
    Lijec Vjesn; 1999 Sep; 121(9-10):296-301. PubMed ID: 19658372
    [Abstract] [Full Text] [Related]

  • 7. On the horizon: can bisphosphonates prevent bone metastases?
    Coleman R.
    Breast; 2007 Dec; 16 Suppl 3():S21-7. PubMed ID: 17988867
    [Abstract] [Full Text] [Related]

  • 8. Approaches to managing bone metastases from breast cancer: the role of bisphosphonates.
    Mystakidou K, Katsouda E, Stathopoulou E, Vlahos L.
    Cancer Treat Rev; 2005 Jun; 31(4):303-11. PubMed ID: 16039956
    [Abstract] [Full Text] [Related]

  • 9. Role of bisphosphonates in prevention and treatment of bone metastases from breast cancer.
    Paterson AH, Kanis JA, Powles TJ, McCloskey E, Hanson J, Ashley S.
    Can J Oncol; 1995 Dec; 5 Suppl 1():54-7. PubMed ID: 8853526
    [Abstract] [Full Text] [Related]

  • 10. Emerging role of bisphosphonates in the clinic--antitumor activity and prevention of metastasis to bone.
    Lipton A.
    Cancer Treat Rev; 2008 Dec; 34 Suppl 1():S25-30. PubMed ID: 18486347
    [Abstract] [Full Text] [Related]

  • 11. The use of bisphosphonates in cancer patients.
    Wu S, Dahut WL, Gulley JL.
    Acta Oncol; 2007 Dec; 46(5):581-91. PubMed ID: 17562434
    [Abstract] [Full Text] [Related]

  • 12. Bisphosphonate therapy for patients with breast carcinoma.
    Plunkett TA, Rubens RD.
    Cancer; 2003 Feb 01; 97(3 Suppl):854-8. PubMed ID: 12548586
    [Abstract] [Full Text] [Related]

  • 13. Antitumor effects and anticancer applications of bisphosphonates.
    Morgan G, Lipton A.
    Semin Oncol; 2010 Oct 01; 37 Suppl 2():S30-40. PubMed ID: 21111246
    [Abstract] [Full Text] [Related]

  • 14. Potential anticancer properties of bisphosphonates.
    Neville-Webbe HL, Gnant M, Coleman RE.
    Semin Oncol; 2010 Jun 01; 37 Suppl 1():S53-65. PubMed ID: 20682373
    [Abstract] [Full Text] [Related]

  • 15. Management of bisphosphonate treatment in clinical practice.
    Aapro MS.
    Semin Oncol; 2007 Dec 01; 34(6 Suppl 4):S28-32. PubMed ID: 18068488
    [Abstract] [Full Text] [Related]

  • 16. The potential role of bisphosphonates in prostate cancer.
    Oades GM, Coxon J, Colston KW.
    Prostate Cancer Prostatic Dis; 2002 Dec 01; 5(4):264-72. PubMed ID: 12627210
    [Abstract] [Full Text] [Related]

  • 17. Should bisphosphonates be utilized in the adjuvant setting for breast cancer?
    Lipton A.
    Breast Cancer Res Treat; 2010 Aug 01; 122(3):627-36. PubMed ID: 20490653
    [Abstract] [Full Text] [Related]

  • 18. Bisphosphonates for the prevention of bone metastases.
    Coleman RE.
    Semin Oncol; 2002 Dec 01; 29(6 Suppl 21):43-9. PubMed ID: 12584694
    [Abstract] [Full Text] [Related]

  • 19. In vitro and in vivo antiresorptive effects of bisphosphonates in metastatic bone disease.
    Kanakis I, Kousidou OCh, Karamanos NK.
    In Vivo; 2005 Dec 01; 19(1):311-8. PubMed ID: 15796191
    [Abstract] [Full Text] [Related]

  • 20. Optimal management of metastatic bone disease.
    Major P.
    Eur J Oncol Nurs; 2007 Dec 01; 11 Suppl 2():S32-7. PubMed ID: 17804294
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.